Patrys Ltd has released a press release.
Appointment of Chief Executive Officer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Patrys
- Appendix 4C - Quarterly - 31 December 2025
- Investor Presentation
- Completion of Acquisition and Board Appointments
- Pipeline Expanded with Proprietary Injectable Antipsychotic
- Trading Halt
Later from Patrys
- Appendix 4D - Half Year Accounts - 31 December 2025
- RLS-2201 Manufacturing and Regulatory Pathway Initiated
- Investor Presentation - Broker Meets Biotech
- $3.2 million Placement to Advance Clinical Trials
- Appendix 4C - Quarterly - 31 March 2026
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys